secwatch.observer — SEC 8-K summary
======================================

Issuer:     Artiva Biotherapeutics, Inc. (ARTV)
CIK:        0001817241
Form:       8-K
Filed at:   2024-07-22T23:59:59+00:00
Accession:  0001193125-24-182231
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Artiva Biotherapeutics files amended charter and bylaws upon IPO closing
------------------------------------------------------------------------

- Amended and restated certificate of incorporation filed with Delaware Secretary of State on July 22, 2024, effective prior to IPO closing.
- Amended and restated bylaws adopted effective July 22, 2024, immediately following IPO closing.
- Both corporate documents were previously approved by board and stockholders in connection with the IPO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817241/000119312524182231/0001193125-24-182231-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817241/000119312524182231/d863184d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-182231

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer